SCHEMBL22462686

SCHEMBL22462686

CC(=O)NC(CCC(=O)N[C@@H](C)C(=O)O)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.52
▸ NOD1 Q9Y239 4/20 0.49
▸ MAPT P10636 2/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ KDM4E B2RXH2 1/20 0.48
▸ THRB P10828 1/20 0.48
▸ ALOX15 P16050 1/20 0.48
▸ NFKB1 P19838 1/20 0.48
▸ PTGS2 P35354 1/20 0.48
▸ THPO P40225 1/20 0.48
▸ RECQL P46063 1/20 0.48
▸ BLM P54132 1/20 0.48
▸ FAAH O00519 3/20 0.46
▸ FOLH1 Q04609 4/20 0.44
▸ NAALAD2 Q9Y3Q0 2/20 0.44
▸ RIMKLA Q8IXN7 1/20 0.44
▸ GNPAT O15228 1/20 0.41
▸ SLC6A5 Q9Y345 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22462687 1.00 ALDH1A1 (0.52) ALDH1A1NOD1MAPTSMN1; SMN2KDM4E
SCHEMBL22462688 1.00 ALDH1A1 (0.52) ALDH1A1NOD1MAPTSMN1; SMN2KDM4E
SCHEMBL15451406 0.84 NOD1 (0.54) ALDH1A1NOD1MAPTSMN1; SMN2KDM4E
SCHEMBL15451404 0.84 NOD1 (0.54) ALDH1A1NOD1MAPTSMN1; SMN2KDM4E
SCHEMBL19718595 0.84 FOLH1 (0.60) ALDH1A1NOD1MAPTSMN1; SMN2KDM4E
SCHEMBL18082026 0.84 FOLH1 (0.60) ALDH1A1NOD1MAPTSMN1; SMN2KDM4E
SCHEMBL14478725 0.84 NOD1 (0.54) ALDH1A1NOD1MAPTSMN1; SMN2KDM4E
SCHEMBL18272425 0.84 FOLH1 (0.60) ALDH1A1NOD1MAPTSMN1; SMN2KDM4E
SCHEMBL15451421 0.84 NOD1 (0.54) ALDH1A1NOD1MAPTSMN1; SMN2KDM4E
SCHEMBL14478726 0.84 NOD1 (0.54) ALDH1A1NOD1MAPTSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230248682-A1 COMPOSITION FOR TREATING ATOPY OR PRURITUS COMPRISING N-ACETYL OR N-ACYL AMINO ACID STEMDR INC. (KR) 2023-08-10 — — US claimed
US-20230248682-A1 COMPOSITION FOR TREATING ATOPY OR PRURITUS COMPRISING N-ACETYL OR N-ACYL AMINO ACID STEMDR INC. (KR) 2023-08-10 — — US disclosed
US-20200316001-A1 COMPOSITION FOR TREATING ATOPY OR PRURITUS CONTAINING N-ACETYL OR N-ACYLAMINO ACID STEMDR INC. (KR) 2020-10-08 — — US disclosed
EP-3714880-A2 COMPOSITION FOR TREATING ATOPY OR PRURITUS COMPRISING N-ACETYL OR N-ACYL AMINO ACID Stemdr Inc. (KR) 2020-09-30 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230248682-A1 COMPOSITION FOR TREATING ATOPY OR PRURITUS COMPRISING N-ACETYL OR N-ACYL AMINO ACID AADAT, NAT1, AANAT ALDH1A1 854/4885NOD1 4232/4885MAPT 1612/4885
US-20200316001-A1 COMPOSITION FOR TREATING ATOPY OR PRURITUS CONTAINING N-ACETYL OR N-ACYLAMINO ACID NAT1, AADAT, AANAT ALDH1A1 594/4885NOD1 4207/4885MAPT 1858/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback